Malaria Parasite Sexual Development, Drug Resistance, and Evolution
Malaria Parasite Sexual Development, Drug Resistance, and Evolution
批准号:
7592263
负责人:
Xinzhuan Su
金额:
$136.96万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
ATP-Binding Cassette TransportersAntigensAntimalarialsBiological ProcessCambodiaChloroquineChromosomes, Human, Pair 14ClinicalCollaborationsCollectionCulicidaeDNADataData AnalysesDevelopmentDevelopmental ProcessDiseaseDrug resistanceEvolutionGene Expression RegulationGenesGeneticGenomeGenotypeGoalsImmuneIn VitroKnock-outMalariaMexicoMolecularMutationNatureNumbersParasitesPatientsPharmaceutical PreparationsPhenotypePlasmodium falciparumPlasmodium vivaxPopulationPopulation DynamicsProcessPublicationsQuinineResistanceResourcesRoleSamplingScientistSexual DevelopmentSingle Nucleotide PolymorphismSingle Nucleotide Polymorphism MapSiteSpecificityTestingWorkbasedensitydesignfunctional genomicsgenome databaseinterestknockout geneparasite genomeresponsetransmission process
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We have finished collecting single nucleotide polymorphisms (SNPs) from 3539 genes on all of the 14 chromosomes of Plasmodium falciparum, leading to a publication in Nature Genetics early this year. In addition to developing genome-wide SNP map, our study also identified many candidate molecules that could be under host immune selection (antigens). Based on the SNPs identified, we have developed a microarray platform (Molecular Inversion Probe or PArAllele) that allows us to genotype large numbers of SNPs in a single hybridization. Parasites are being collected from patients at our clinical field site in Cambodia. Many of the parasites have been adapted and grown in in vitro culture. DNA samples from the parasites are being prepared for hybridization. We also have been evaluating a high-density microarray with 2.5 million probes for genotyping and other studies. Our data suggested that this high-density array could be a good alternative for SNP typing. The parasite responses to different antimalarial drugs are being tested to identify mutations potentially contributing to drug resistances.
Another project we are working on is ABC transporters and their roles in drug resistance in P. falaciprum. We have genetically knockout one of the ABC transporters associated with chloroquine and quinine resistances in our pervious study and are evaluating the effects of gene knockout on parasite drug responses.
We have finished the data analyses of our ESTcDNA collection. Our data showed considerable gene prediction inaccuracy in the P. falciparum.
In collaboration with scientists in Mexico, we have also been studying Plasmodium vivax populations and their host specificity in Southern Mexico. Our data showed that P. vivax population there could be divided into three populations that were transmitted by two different mosquito species with different efficiency. This study can potentially provide information for better understanding of the molecular mechanisms of parasite and host interaction (or host specificity).
We are still interested in various aspects of parasite sexual development, particularly the biological functions of Pfmdv1 and other genes that may involve in the process of gametocyte development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Malaria Parasite Development, Drug Resistance, and Genomics
-
批准号:8336151
-
项目类别:
-
资助金额:$93.88万
-
财政年份:--
-
负责人:Xinzhuan Su
-
依托单位:
Malaria Parasite Sexual Development, Drug Resistance, and Evolution
-
批准号:7732562
-
项目类别:
-
资助金额:$104.06万
-
财政年份:--
-
负责人:Xinzhuan Su
-
依托单位:
Malaria Parasite Development, Drug Resistance, Pathogenesis, and Genomics
-
批准号:8946351
-
项目类别:
-
资助金额:$134.18万
-
财政年份:--
-
负责人:Xinzhuan Su
-
依托单位:
Genomic/Genetic Approach To Malaria Parasite Development
-
批准号:6507113
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Xinzhuan Su
-
依托单位:
Malaria Parasite Sexual Development, Drug Resistance, an
-
批准号:7303881
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Xinzhuan Su
-
依托单位:
Malaria Parasite Sexual Development and Drug Resistance
-
批准号:7196685
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Xinzhuan Su
-
依托单位:
Malaria Parasite Sexual Development, Drug Resistance, an
-
批准号:6669897
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Xinzhuan Su
-
依托单位:
Malaria Parasite Development, Drug Resistance, and Genomics
-
批准号:8555855
-
项目类别:
-
资助金额:$90.01万
-
财政年份:--
-
负责人:Xinzhuan Su
-
依托单位:
Malaria Parasite Development, Drug Resistance, Pathogenesis, and Genomics
-
批准号:9563887
-
项目类别:
-
资助金额:$152.01万
-
财政年份:--
-
负责人:Xinzhuan Su
-
依托单位:
Malaria Parasite Development, Drug Resistance, Pathogenesis, and Genomics
-
批准号:10014086
-
项目类别:
-
资助金额:$164.33万
-
财政年份:--
-
负责人:Xinzhuan Su
-
依托单位:
Malaria Parasite Development, Drug Resistance, Pathogenesis, and Genomics
-
批准号:9161533
-
项目类别:
-
资助金额:$142.35万
-
财政年份:--
-
负责人:Xinzhuan Su
-
依托单位:
Malaria Parasite Genomics, Development, Drug Resistance, Pathogenesis, and host-parasite interaction
-
批准号:10692069
-
项目类别:
-
资助金额:$134.84万
-
财政年份:--
-
负责人:Xinzhuan Su
-
依托单位:
Malaria Parasite Sexual Development, Drug Resistance, an
-
批准号:6809127
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Xinzhuan Su
-
依托单位:
Malaria Parasite Development, Drug Resistance, and Gemonics
-
批准号:8156930
-
项目类别:
-
资助金额:$111.99万
-
财政年份:--
-
负责人:Xinzhuan Su
-
依托单位:
Malaria Parasite Sexual Development, Drug Resistance
-
批准号:6987001
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Xinzhuan Su
-
依托单位:
Malaria Parasite Sexual Development, Drug Resistance, and Evolution
-
批准号:7964450
-
项目类别:
-
资助金额:$110.31万
-
财政年份:--
-
负责人:Xinzhuan Su
-
依托单位:
Malaria Parasite Development, Drug Resistance, Pathogenesis, and Genomics
-
批准号:8745387
-
项目类别:
-
资助金额:$124.23万
-
财政年份:--
-
负责人:Xinzhuan Su
-
依托单位:
Malaria Parasite Genomics, Development, Drug Resistance, Pathogenesis, and host-parasite interaction
-
批准号:10272084
-
项目类别:
-
资助金额:$152.56万
-
财政年份:--
-
负责人:Xinzhuan Su
-
依托单位:
Malaria Parasite Genomics, Development, Drug Resistance, Pathogenesis, and host-parasite interaction
-
批准号:10927775
-
项目类别:
-
资助金额:$155.95万
-
财政年份:--
-
负责人:Xinzhuan Su
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: